Những nghiên cứu phân tích về COVID-19 (ngày 25/2 - 4/3/2022)

Cục Thông tin khoa học và công nghệ quốc gia trân trọng kính gửi đến các nhà khoa học những xu hướng nghiên cứu về COVID-19 hiện nay. Bao gồm những bài viết đã được xuất bản chính thức và các bài viết được chấp nhận đăng trên những cơ sở dữ liệu học thuật chính thống. Những nghiên cứu công bố trước thời gian này được tổng hợp tại đường link cuối bài. 

PUBMED

1. The coronavirus disease (COVID-19) - A supportive approach with selected micronutrients.

Gröber U, Holick MF.

Int J Vitam Nutr Res. 2022 Jan;92(1):13-34. doi: 10.1024/0300-9831/a000693. Epub 2021 Jan 25.

PMID: 33487035

https://econtent.hogrefe.com/doi/epdf/10.1024/0300-9831/a000693

2. COVID-19 vaccination intention in the first year of the pandemic: A systematic review.

Al-Amer R, Maneze D, Everett B, Montayre J, Villarosa AR, Dwekat E, Salamonson Y.

J Clin Nurs. 2022 Jan;31(1-2):62-86. doi: 10.1111/jocn.15951. Epub 2021 Jul 6.

PMID: 34227179

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8447353/pdf/JOCN-9999-0.pdf

3. COVID-19 diagnosis using state-of-the-art CNN architecture features and Bayesian Optimization.

Aslan MF, Sabanci K, Durdu A, Unlersen MF.

Comput Biol Med. 2022 Mar;142;105244. doi: 10.1016/j.compbiomed.2022.105244. Epub 2022 Jan 20.

PMID: 35077936

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8770389/pdf/main.pdf

4. Epidemiologic characteristics of cases with reinfection, recurrence, and hospital readmission due to COVID-19: A systematic review and meta-analysis.

Sotoodeh Ghorbani S, Taherpour N, Bayat S, Ghajari H, Mohseni P, Hashemi Nazari SS.

J Med Virol. 2022 Jan;94(1):44-53. doi: 10.1002/jmv.27281. Epub 2021 Aug 27.

PMID: 34411311

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8507360/pdf/10903_2021_Article_1290.pdf

5. In-line treatments and clinical initiatives to fight against COVID-19 outbreak.

Agrawal M, Saraf S, Saraf S, Murty US, Kurundkar SB, Roy D, Joshi P, Sable D, Choudhary YK, Kesharwani P, Alexander A.

Respir Med. 2022 Jan; 191:106192. doi: 10.1016/j.rmed.2020.106192. Epub 2020 Oct 17.

PMID: 33199136

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7567661/pdf/main.pdf

6. COVID-19 Radiology Preparedness, Challenges & Opportunities: Responses From 18 Countries.

Rehani B, Rodriguez JA, Nguyen JK, Patel MM, Ammanuel SG, Winford E, Dillon WP.

Curr Probl Diagn Radiol. 2022 Mar-Apr;51(2):196-203. doi: 10.1067/j.cpradiol.2021.03.017. Epub 2021 Apr 24.

PMID: 33994227

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8064895/pdf/main.pdf

7. Performance of the BinaxNOW coronavirus disease 2019 (COVID-19) Antigen Card test relative to the severe acute respiratory coronavirus virus 2 (SARS-CoV-2) real-time reverse transcriptase polymerase chain reaction (rRT-PCR) assay among symptomatic and asymptomatic healthcare employees.

James AE, Gulley T, Kothari A, Holder K, Garner K, Patil N.

Infect Control Hosp Epidemiol. 2022 Jan;43(1):99-101. doi: 10.1017/ice.2021.20. Epub 2021 Jan 25.

PMID: 33487197

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7870908/pdf/S0899823X21000209a.pdf

8. Symptoms COVID 19 Positive Vapers Compared to COVID 19 Positive Non-vapers.

McFadden DD, Bornstein SL, Vassallo R, Salonen BR, Bhuiyan MN, Schroeder DR, Croghan IT.

J Prim Care Community Health. 2022 Jan-Dec;13:21501319211062672. doi: 10.1177/21501319211062672.

PMID: 34986700  

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8744181/pdf/10.1177_21501319211062672.pdf

9. Review and classification of AI-enabled COVID-19 CT imaging models based on computer vision tasks.

Hassan H, Ren Z, Zhao H, Huang S, Li D, Xiang S, Kang Y, Chen S, Huang B.

Comput Biol Med. 2022 Feb;141:105123. doi: 10.1016/j.compbiomed.2021.105123. Epub 2021 Dec 18.

PMID: 34953356

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8684223/pdf/main.pdf

10. COVID-19 diagnostics: preserving manufacturing capacity for future pandemics.

Hannay E, Fernández-Suárez M, Duneton P.

BMJ Glob Health. 2022 Feb;7(2):e007494. doi: 10.1136/bmjgh-2021-007494.

PMID: 35149552 

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8844951/pdf/bmjgh-2021-007494.pdf

11. Advancements in detection of SARS-CoV-2 infection for confronting COVID-19 pandemics.

Zhou Y, Zhang L, Xie YH, Wu J.

Lab Invest. 2022 Jan;102(1):4-13. doi: 10.1038/s41374-021-00663-w. Epub 2021 Sep 8.

PMID: 34497366

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8424153/pdf/41374_2021_Article_663.pdf

12. Mental health status of COVID-19 survivors: a cross sectional study.

Jafri MR, Zaheer A, Fatima S, Saleem T, Sohail A.

Virol J. 2022 Jan 6;19(1):3. doi: 10.1186/s12985-021-01729-3.

PMID: 34991632

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8733909/pdf/12985_2021_Article_1729.pdf

13. Analyzing COVID-19 Vaccination Behavior Using an SEIRM/V Epidemic Model With Awareness Decay.

Zuo C, Zhu F, Ling Y.

Front Public Health. 2022 Jan 27;10:817749. doi: 10.3389/fpubh.2022.817749. eCollection 2022.

PMID: 35155327

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8829349/pdf/fpubh-10-817749.pdf

14. Why Physical Activity Should Be Considered in Clinical Trials for COVID-19 Vaccines: A Focus on Risk Groups.

Bortolini MJS, Petriz B, Mineo JR, Resende RO.

Int J Environ Res Public Health. 2022 Feb 7;19(3):1853. doi: 10.3390/ijerph19031853.

PMID: 35162875

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8834774/pdf/ijerph-19-01853.pdf

15. Prior COVID-19 infection is associated with increased Adverse Events (AEs) after the first, but not the second, dose of the BNT162b2/Pfizer vaccine.

Raw RK, Rees J, Kelly CA, Wroe C, Chadwick DR.

Vaccine. 2022 Jan 24;40(3):418-423. doi: 10.1016/j.vaccine.2021.11.090. Epub 2021 Dec 4.

PMID: 34895935

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8642150/pdf/main.pdf

16. Justifying the risks of COVID-19 challenge trials: The analogy with organ donation.

Jayaram A, Sparks J, Callies D.

Bioethics. 2022 Jan;36(1):100-106. doi: 10.1111/bioe.12889. Epub 2021 Jun 27.

PMID: 34180072

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8444865/pdf/BIOE-9999-0.pdf

SCIENCEDIRECT

1. Guillain-Barre syndrome: An autoimmune disorder post-COVID-19 vaccination?

Clinical Immunology Communications, 23 December 2021, Volume 2 (Cover date: December 2022), Pages 1-5

Zafran Khan, Ubaid Ahmad, Nasib Zaman
https://www.sciencedirect.com/science/article/pii/S2772613421000147/pdfft?md5=f005b5e6811cb9abe9678febb5aa3d6a&pid=1-s2.0-S2772613421000147-main.pdf

2. RCSB Protein Data Bank resources for structure-facilitated design of mRNA vaccines for existing and emerging viral pathogens
Structure, 4 November 2021, Volume 30, Issue 1 (Cover date: 6 January 2022), Pages 55-68.e2

David S. Goodsell, Stephen K. Burley

https://www.sciencedirect.com/science/article/pii/S0969212621003762/pdfft?md5=2362927393c4561d49ade893b3a363e1&pid=1-s2.0-S0969212621003762-main.pdf

3. Isothermal gene amplification coupled MALDI-TOF MS for SARS-CoV-2 detection

Talanta, 8 February 2022, Volume 242 (Cover date: 15 May 2022), Article 123297

Guobin Han, Qiuyuan Lin, Liang Qiao
https://www.sciencedirect.com/science/article/pii/S0039914022000935/pdfft?md5=8f165b28cdd4a99fcf9a164a921ae2e7&pid=1-s2.0-S0039914022000935-main.pdf

4. Immune responses to human respiratory coronaviruses infection in mouse models
Current Opinion in Virology, 11 December 2021, Volume 52 (Cover date: February 2022), Pages 102-111

Zhen Zhuang, Donglan Liu, Jincun Zhao

https://www.sciencedirect.com/science/article/pii/S1879625721001565/pdfft?md5=7c5a92231b080e575bbb3ea8bad21656&pid=1-s2.0-S1879625721001565-main.pdf

5. Clinical features and mechanistic insights into drug repurposing for combating COVID-19

The International Journal of Biochemistry & Cell Biology, 5 November 2021, Volume 142 (Cover date: January 2022), Article 106114

Purva Asrani, Keshav Tiwari, Sukhwinder Singh Sohal
https://www.sciencedirect.com/science/article/pii/S1357272521001953/pdfft?md5=76d0589ff5d346d116450b5eb9398db6&pid=1-s2.0-S1357272521001953-main.pdf

6. Longitudinal immune profiling reveals dominant epitopes mediating long-term humoral immunity in COVID-19–convalescent individuals

Journal of Allergy and Clinical Immunology, Available online 21 January 2022, In press, corrected proof

Min Li, Jiaojiao Liu, Xia Jin
https://www.sciencedirect.com/science/article/pii/S0091674922000732/pdfft?md5=f754a0facc897afd8f93e06c1c620447&pid=1-s2.0-S0091674922000732-main.pdf

7. Humoral anti-SARS-CoV-2 immune response after two doses of Comirnaty vaccine in nursing home residents by previous infection status

Vaccine, 3 December 2021, Volume 40, Issue 3 (Cover date: 24 January 2022), Pages 531-535

François Helle, Julien Moyet, Etienne Brochot
https://www.sciencedirect.com/science/article/pii/S0264410X21015589/pdfft?md5=86908ab28df9794e218c8dcfc3979ebb&pid=1-s2.0-S0264410X21015589-main.pdf

8. Establishment of a pseudovirus neutralization assay based on SARS-CoV-2 S protein incorporated into lentiviral particles
Biosafety and Health, Available online 3 January 2022, In press, corrected proof

Sheng Wang, Lizhen Liu, Hong Shao

https://www.sciencedirect.com/science/article/pii/S2590053621001269/pdfft?md5=a5a5258a5e01f2835032ece3498a7087&pid=1-s2.0-S2590053621001269-main.pdf

9. Exhausted NK cells and cytokine storms in COVID-19: Whether NK cell therapy could be a therapeutic choice
Human Immunology, 8 September 2021, Volume 83, Issue 1 (Cover date: January 2022), Pages 86-98

Mehran Ghasemzadeh, Alireza Ghasemzadeh, Ehteramolsadat Hosseini

https://www.sciencedirect.com/science/article/pii/S0198885921002305/pdfft?md5=158972f8afc98ec907424a6c4bf599f4&pid=1-s2.0-S0198885921002305-main.pdf

10. The role of microRNAs in solving COVID-19 puzzle from infection to therapeutics: A mini-review
Virus Research, 14 November 2021, Volume 308 (Cover date: 15 January 2022), Article 198631

Sujay Paul, Luis Alberto Bravo Vázquez, Aashish Srivastava

https://www.sciencedirect.com/science/article/pii/S0168170221003385/pdfft?md5=f57b4fa55d64cb501aa7ee9ca1f32c4e&pid=1-s2.0-S0168170221003385-main.pdf

11. Seroconversion rate after vaccination against COVID-19 in patients with cancer-a systematic review
Annals of Oncology, 28 October 2021, Volume 33, Issue 2 (Cover date: February 2022), Pages 158-168

C. Corti, G. Antonarelli, G. Curigliano
https://www.sciencedirect.com/science/article/pii/S0923753421045506/pdfft?md5=1ebb3081fc3dadd6084d475de21ca114&pid=1-s2.0-S0923753421045506-main.pdf

12. Probing the formation, structure and free energy relationships of M protein dimers of SARS-CoV-2

Computational and Structural Biotechnology Journal, 11 January 2022, Volume 20 (Cover date: 2022), Pages 573-582

Yipeng Cao, Rui Yang, Zhiyong Yuan

https://www.sciencedirect.com/science/article/pii/S2001037022000149/pdfft?md5=01f3be50d0558f8fd6173cc2c9d34e89&pid=1-s2.0-S2001037022000149-main.pdf

WILEY

1. Identification of SARS-CoV-2 Papain-like Protease (PLpro) Inhibitors Using Combined Computational Approach

Dr. Milan Sencanski,Dr. Vladimir Perovic,Dr. Jelena Milicevic,Dr. Tamara Todorovic,Dr. Radivoje Prodanovic,Dr. Veljko Veljkovic,Dr. Slobodan Paessler,Dr. Sanja Glisic

First published: 01 February 2022

https://chemistry-europe.onlinelibrary.wiley.com/doi/epdf/10.1002/open.202100248

2. Identification of potential target endoribonuclease NSP15 inhibitors of SARS-COV-2 from natural products through high-throughput virtual screening and molecular dynamics simulation

Liang-Chang Hu,Chuan-Hua Ding,Hong-Ying Li,Zhen-Zhen Li,Ying Chen,Li-Peng Li,Wan-Zhong Li,Wen-Shan Liu

First published: 06 February 2022

https://onlinelibrary.wiley.com/doi/epdf/10.1111/jfbc.14085

3. SARS-CoV-2 variants preferentially emerge at intrinsically disordered protein sites helping immune evasion

Federica Quaglia,Edoardo Salladini,Marco Carraro,Giovanni Minervini,Silvio C.E. Tosatto,Philippe Le Mercier

First published: 02 February 2022

https://febs.onlinelibrary.wiley.com/doi/epdf/10.1111/febs.16379

4. Persistence of Ad26.COV2.S-associated VITT and specific detection of VITT antibodies

Adam J. Kanack PhD,Bandana Singh PhD,Gemlyn George MBBS,Krishna Gundabolu MBBS MS,Scott A. Koepsell MD PhD,Mouhamed Yazan Abou-Ismail MD,Karen A. Moser MD

First published: 07 February 2022

https://onlinelibrary.wiley.com/doi/epdf/10.1002/ajh.26488

5. A computational comparative analysis of the binding mechanism of molnupiravir's active metabolite to RNA-dependent RNA polymerase of wild-type and Delta subvariant AY.4 of SARS-CoV-2

Ismail Celik,Trina E. Tallei

First published: 07 February 2022

https://onlinelibrary.wiley.com/doi/epdf/10.1002/jcb.30226

6. Multisystem screening reveals SARS-CoV-2 in neurons of the myenteric plexus and in megakaryocytes

Sandra Gray-Rodriguez,Melanie P. Jensen,Maria Otero-Jimenez,Brian Hanley,Olivia C. Swann,Patrick A. Ward,Francisco J. Salguero,Nadira Querido,Ildiko Farkas,Elisavet Velentza-Almpani …

First published: 02 February 2022

https://onlinelibrary.wiley.com/doi/epdf/10.1002/path.5878

7. Successful Early Use of Anti-SARS-CoV-2 Monoclonal Neutralizing Antibodies in SARS-CoV-2 Infected Hematological Patients – A Czech Multicenter Experience

Barbora Weinbergerová,Ivo Demel,Benjamin Víšek,Jan Válka,Martin Čerňan,Pavel Jindra,Jan Novák,Lukáš Stejskal,Flóra Kovácsová,Tomáš Kabut,Tomáš Szotkowski,Roman Hájek …

First published: 04 February 2022

https://onlinelibrary.wiley.com/doi/epdf/10.1002/hon.2974

8. The emergence and epidemic characteristics of the highly mutated SARS-CoV-2 Omicron variant

Dandan Tian,Yanhong Sun,Huihong Xu,Qing Ye

First published: 03 February 2022

https://onlinelibrary.wiley.com/doi/epdf/10.1002/jmv.27643

9. Comparing humoral immune response to SARS-CoV2 vaccines in multiple sclerosis and healthy controls: an Austrian prospective multi-center cohort study

Gabriel Bsteh,Harald Hegen,Gerhard Traxler,Nik Krajnc,Fritz Leutmezer,Franziska Di Pauli,Barbara Kornek,Paulus Rommer,Gudrun Zulehner,Sophie Dürauer,Angelika Bauer …

First published: 01 February 2022

https://onlinelibrary.wiley.com/doi/epdf/10.1111/ene.15265

10. Clinical impact and benefits of a simultaneous cardio-pulmonary rehabilitation in a COVID-19-infected patient following cardiac arrest: A case report

Mirim Lee,Jeong Jae Lee,Jun young Ko,Yong Kyun Kim,Seungbok Lee

First published: 02 February 2022

https://onlinelibrary.wiley.com/doi/epdf/10.1002/ccr3.5345

SPRINGER NATURE

1. Pre-COVID-19 Social Determinants of Health Among Mexican Migrants in Los Angeles and New York City and Their Increased Vulnerability to Unfavorable Health Outcomes During the COVID-19 Pandemic

Mireya Vilar-Compte, Pablo Gaitán-Rossi… in Journal of Immigrant and Minority Health (2022)

https://link.springer.com/content/pdf/10.1007%2Fs10903-021-01283-8.pdf

2. Long COVID: rheumatologic/musculoskeletal symptoms in hospitalized COVID-19 survivors at 3 and 6 months

Fatih Karaarslan, Fulya Demircioğlu Güneri, Sinan Kardeş in Clinical Rheumatology (2022)

https://link.springer.com/content/pdf/10.1007%2Fs10067-021-05942-x.pdf

3. Low in-hospital mortality rate in patients with COVID-19 receiving thromboprophylaxis: data from the multicentre observational START-COVID Register

Daniela Poli, Emilia Antonucci, Walter Ageno… in Internal and Emergency Medicine (2022)

https://link.springer.com/content/pdf/10.1007%2Fs11739-021-02891-w.pdf

4. Applications of nanomaterials in COVID-19 pandemic

Mei-Fang Xiao, Chang Zeng, Shao-Hui Li, Fu-Lai Yuan in Rare Metals (2022)

https://link.springer.com/content/pdf/10.1007%2Fs12598-021-01789-y.pdf

5. Increased psychological distress after the lifting of COVID-19 lockdown in the Saudi population: a cross-sectional study

Hatim Yousef Alharbi, Sami S. Alharthi… in Middle East Current Psychiatry (2022)

https://link.springer.com/content/pdf/10.1186%2Fs43045-021-00167-9.pdf

6. The impact of COVID-19 on surgical procedures in Japan: analysis of data from the National Clinical Database

Norihiko Ikeda, Hiroyuki Yamamoto, Akinobu Taketomi, Taizo Hibi… in Surgery Today (2022)

https://link.springer.com/content/pdf/10.1007%2Fs00595-021-02406-2.pdf

7. The moderating effect of solar radiation on the association between human mobility and COVID-19 infection in Europe

Wenyu Zhao, Yongjian Zhu, Jingui Xie… in Environmental Science and Pollution Resear… (2022)

https://link.springer.com/content/pdf/10.1007%2Fs11356-021-15738-w.pdf

Các công bố về COVID-19 trước thời gian trên:

Cập nhật các công bố về COVID-19 từ ngày 18/02 đến ngày 25/02/2022

https://vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/vac-xin-covid-19-va-nhung-xu-huong-nghien-cuu-ngay-18-2-25-2-2022-4707.html

Cập nhật các công bố về COVID-19 từ ngày 11/02 đến ngày 18/02/2022

https://vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/covid-19-va-nhung-tac-dong-doi-voi-doi-song-ngay-11-18-2-2022-4685.html

Cập nhật các công bố về COVID-19 từ ngày 04/02 đến ngày 11/02/2022

https://vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/nghien-cuu-moi-ve-covid-19-tu-ngay-4-2-den-ngay-11-2-2022-4664.html

Cập nhật các công bố về COVID-19 từ ngày 21/01 đến ngày 28/01/2022

https://vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/nghien-cuu-moi-ve-vaccine-covid-19-tu-ngay-21-01-den-ngay-28-01-2022-4639.html

Cập nhật các công bố về COVID-19 từ ngày 14/01 đến ngày 21/01/2022

https://vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/nghien-cuu-moi-ve-vaccine-covid-19-tu-ngay-14-1-den-ngay-21-1-2022-4618.html

Cập nhật các công bố về COVID-19 từ ngày 7/01 đến ngày 14/01/2022

https://vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/nghien-cuu-moi-ve-vaccine-covid-19-tu-ngay-7-1-den-ngay-14-1-2022-4601.html

Cập nhật các công bố về COVID-19 từ ngày 01/01 đến ngày 7/01/2022

https://vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/nghien-cuu-moi-ve-vaccine-covid-19-tu-ngay-3-1-den-ngay-7-1-2022-4584.html

Nguồn: Cục Thông tin khoa học và công nghệ quốc gia, 4/3/2022